Gliomas originate from the supportive tissue of the brain (glial cells). There are several types, including astrocytomas. Astrocytomas are named after astrocytes, the star-shaped glial cells which support and regulate electrical impulses in the brain. These tumors are classified into four grades that reflect their degree of severity. Low-grade tumors are slow growing, generally affect young patients and have a good chance of successful treatment.
Meet the specialists at the Gerald J. Glasser Brain Tumor Center who are experts in treating low-grade astrocytomas and gliomas.Meet the Team
Pilocytic astrocytomas – these grade I tumors are found most frequently in children and young adults.
Diffuse astrocytomas – the most common low-grade astrocytoma, these grade II tumors generally develop in adults.
Symptoms, which may develop over an extended period of time, can include:
Low-grade gliomas and astrocytomas are diagnosed through a neurological examination followed by a computed tomography (CT) or magnetic resonance imaging (MRI) scan of the brain. MRI scans are usually performed with contrast dye to help identify the tumor’s size, location and type. These tumors tend to be clearly visible on imaging scans.
An exact diagnosis can only be confirmed following a stereotactic biopsy or surgical removal of the tumor. Tissue analysis by a neuropathologist defines the diagnosis and genetic profile of the tumor.
Surgery - Treatment for low-grade gliomas and astrocytomas typically starts with surgical removal of the tumor. We use the latest techniques to make craniotomy (surgical opening of the skull) as safe and effective as possible. These include:
Alternatively, a biopsy could be performed in patients with medical conditions that don't allow for surgery – or when there are concerns about the location of the tumor.
Total surgical removal can be a cure for some pilocytic astrocytomas, which have sharply defined edges. However, surgery is combined with additional treatments for other low-grade tumors and diffuse astrocytomas that have spread to surrounding brain tissue.
Once a tumor is removed, the diagnosis and molecular profile is individually reviewed by our multidisciplinary tumor board. Together, our experts recommend the best personalized and targeted treatment options incorporating the latest molecular diagnostics, treatment protocols and participation in national clinical trials.
Post-surgical treatment - The next steps are determined by the exact tumor type and grade, the molecular profile of the tumor and the extent of your removal surgery. Insights from our genetic and molecular analysis of your tumor can help predict responsiveness to chemotherapy and other treatments. Treatments could include:
Our team will closely monitor you and personalize your follow-up care. Our care navigator will also connect you with our support group and other resources.